Related Experiment Video

Updated: Sep 19, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Correction: Case Report: Exceptional survival with immunotherapy in a patient with EGFR exon 20 insertion

Shasha Zhao1, Yuanhang Chen1, Meiying Kuang1

  • 1Department of Oncology, Xingyi People's Hospital, Xingyi, China.

Frontiers in Immunology
|September 18, 2026
PubMed

Keywords:
EGFR ex20insPD-L1 high expressionlong-term survivalnon-small cell lung cancertislelizumab

More Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Related Concept Videos